still at discovery stage according to the market if we attribute...

  1. 3,401 Posts.
    lightbulb Created with Sketch. 3216
    still at discovery stage according to the market if we attribute any value at all to AML.

    to be in the money for Nov oppies something big has to happen. We have to have something to license, AML (P2/P3) CPACS (P1/P2) not yet validated and not likely in 2025), or KPACS/DACS (preclinical), or 39 hits (discovery).

    Race building up a nice little pipeline across all stages of development, good to commercialise something AML is ready to rumble - Astex need to step up to the plate.

    Blackout needs to be good and timely, let’s see what the Race team can pull off, no pressure!…
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.22
Change
-0.065(5.06%)
Mkt cap ! $211.9M
Open High Low Value Volume
$1.29 $1.29 $1.21 $205.4K 165.5K

Buyers (Bids)

No. Vol. Price($)
1 788 $1.22
 

Sellers (Offers)

Price($) Vol. No.
$1.23 42 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.